Dronedarone
Dronedarone is a pharmaceutical drug with 19 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
8 of 12 finished
33.3%
4 ended early
0
trials recruiting
19
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dronedarone Rhythm Intervention for Early Atrial Fibrillation
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
Clinical Trials (19)
Dronedarone Rhythm Intervention for Early Atrial Fibrillation
Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation
Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation
Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation
Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation
Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG
Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)
SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI
Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)
Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial Fibrillation
Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent Pacemakers
Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement
Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard Therapy
Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation
Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)
Dronaderone to Prevent Recurrent Implantable Cardioverter Defibrillator (ICD) Shocks
Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus Rhythm
Dronedarone in Pacemakers Patients With Paroxysmal Atrial Fibrillation
All 19 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 19